PL2747561T3 - Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej - Google Patents
Leczenie objawów związanych z gastroparezą u osobników płci żeńskiejInfo
- Publication number
- PL2747561T3 PL2747561T3 PL12825447T PL12825447T PL2747561T3 PL 2747561 T3 PL2747561 T3 PL 2747561T3 PL 12825447 T PL12825447 T PL 12825447T PL 12825447 T PL12825447 T PL 12825447T PL 2747561 T3 PL2747561 T3 PL 2747561T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- symptoms associated
- female gastroparesis
- gastroparesis
- female
- Prior art date
Links
- 206010021518 Impaired gastric emptying Diseases 0.000 title 1
- 208000001288 gastroparesis Diseases 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527563P | 2011-08-25 | 2011-08-25 | |
| US201261583447P | 2012-01-05 | 2012-01-05 | |
| EP12825447.1A EP2747561B1 (en) | 2011-08-25 | 2012-08-23 | Treatment of symptoms associated with female gastroparesis |
| PCT/US2012/052096 WO2013028882A1 (en) | 2011-08-25 | 2012-08-23 | Treatment of symptoms associated with female gastroparesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2747561T3 true PL2747561T3 (pl) | 2018-11-30 |
Family
ID=47746868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12825447T PL2747561T3 (pl) | 2011-08-25 | 2012-08-23 | Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20130217775A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2747561B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2014524478A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103957707A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014004418A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2846340A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2747561T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2683042T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX356317B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2747561T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2747561T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2616520C2 (cg-RX-API-DMAC7.html) |
| TR (1) | TR201811221T4 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013028882A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| WO2018112061A1 (en) * | 2016-12-15 | 2018-06-21 | Evoke Pharma, Inc. | Treatment of moderate and severe gastroparesis |
| WO2018191584A1 (en) * | 2017-04-14 | 2018-10-18 | The Johns Hopkins University | Nutritional and therapeutic supplement compositions |
| SG11201912266QA (en) * | 2017-07-31 | 2020-01-30 | Theravance Biopharma R&D Ip Llc | Methods of treating symptoms of gastroparesis using velusetrag |
| MX2020002682A (es) * | 2017-09-11 | 2020-10-05 | Evoke Pharma Inc | Metodos de dosificacion intranasal de metoclopramida. |
| CN113354553B (zh) * | 2021-06-03 | 2023-09-15 | 北京宝诺康医药科技有限公司 | 一种甲氧氯普胺单盐酸盐一水合物的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL281394A (cg-RX-API-DMAC7.html) | 1961-07-25 | |||
| US4624965A (en) | 1984-11-15 | 1986-11-25 | Nastech Pharmaceutical Co., Inc. | Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same |
| US5760086A (en) | 1996-03-14 | 1998-06-02 | Ribogene, Inc. | Nasal administration of agents for treatment of delayed onset emesis |
| HUP9902891A3 (en) * | 1997-03-13 | 2000-11-28 | Ribogene Inc Hayward | Intranasal administration of a metoclopramide containing spray for treatment of delayed onset emesis |
| US6187332B1 (en) * | 1999-06-14 | 2001-02-13 | Wisconsin Alumni Research Foundation | Acidic buffered nasal spray |
| GB9918559D0 (en) * | 1999-08-07 | 1999-10-06 | Glaxo Wellcome Kk | Novel pharmaceutical formulation |
| US6770262B2 (en) * | 2000-03-30 | 2004-08-03 | Questcor Pharmaceuticals, Inc. | Nasal administration of agents for the treatment of gastroparesis |
| US20030044356A1 (en) * | 2001-04-20 | 2003-03-06 | Jin Auh | Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one) |
| US20050137265A1 (en) | 2003-03-31 | 2005-06-23 | Haley Eugene T. | Rapidly dissolving metoclopramide solid oral dosage and method thereof |
| US20050175679A1 (en) * | 2004-02-10 | 2005-08-11 | Michael Moshman | Controlled release formulations |
| CA3155873C (en) | 2008-12-22 | 2024-03-19 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| CN102361552A (zh) * | 2009-03-23 | 2012-02-22 | 莱拉制药用品私营有限责任公司 | 用于治疗过敏性眼/鼻疾病的姜黄色素及其代谢物 |
-
2012
- 2012-08-23 CA CA2846340A patent/CA2846340A1/en active Pending
- 2012-08-23 DK DK12825447.1T patent/DK2747561T3/en active
- 2012-08-23 TR TR2018/11221T patent/TR201811221T4/tr unknown
- 2012-08-23 WO PCT/US2012/052096 patent/WO2013028882A1/en not_active Ceased
- 2012-08-23 CN CN201280052214.2A patent/CN103957707A/zh active Pending
- 2012-08-23 MX MX2014002125A patent/MX356317B/es active IP Right Grant
- 2012-08-23 EP EP12825447.1A patent/EP2747561B1/en active Active
- 2012-08-23 RU RU2014111070A patent/RU2616520C2/ru active
- 2012-08-23 PL PL12825447T patent/PL2747561T3/pl unknown
- 2012-08-23 ES ES12825447.1T patent/ES2683042T3/es active Active
- 2012-08-23 US US13/593,215 patent/US20130217775A1/en not_active Abandoned
- 2012-08-23 JP JP2014527302A patent/JP2014524478A/ja active Pending
- 2012-08-23 BR BR112014004418A patent/BR112014004418A8/pt not_active Application Discontinuation
- 2012-08-23 PT PT128254471T patent/PT2747561T/pt unknown
-
2017
- 2017-07-27 JP JP2017145855A patent/JP6511492B2/ja active Active
-
2018
- 2018-10-29 JP JP2018203340A patent/JP2019031551A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2616520C2 (ru) | 2017-04-17 |
| EP2747561A1 (en) | 2014-07-02 |
| CN103957707A (zh) | 2014-07-30 |
| BR112014004418A2 (pt) | 2017-03-28 |
| JP2014524478A (ja) | 2014-09-22 |
| RU2014111070A (ru) | 2015-09-27 |
| WO2013028882A1 (en) | 2013-02-28 |
| MX2014002125A (es) | 2014-10-17 |
| MX356317B (es) | 2018-05-23 |
| TR201811221T4 (tr) | 2018-08-27 |
| EP2747561A4 (en) | 2014-12-24 |
| JP6511492B2 (ja) | 2019-05-15 |
| ES2683042T3 (es) | 2018-09-24 |
| DK2747561T3 (en) | 2018-08-06 |
| JP2019031551A (ja) | 2019-02-28 |
| JP2018008979A (ja) | 2018-01-18 |
| CA2846340A1 (en) | 2013-02-28 |
| PT2747561T (pt) | 2018-09-28 |
| EP2747561B1 (en) | 2018-05-09 |
| US20130217775A1 (en) | 2013-08-22 |
| BR112014004418A8 (pt) | 2018-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2717855A4 (en) | PROCESSING METHODS | |
| EP2820139A4 (en) | BIOMASS TREATMENT | |
| IL233111A0 (en) | Preparations for the treatment of inflammation | |
| PT2747561T (pt) | Tratamento de sintomas associados com a gastroparesia feminina | |
| GB201309274D0 (en) | Treatment Of Fuel | |
| ZA201402154B (en) | Treatment of coal | |
| ZA201308117B (en) | Avian-based treatment | |
| ZA201308176B (en) | Therapeutic treatment | |
| GB201107467D0 (en) | Novel treatment of pain | |
| GB201102283D0 (en) | Treatment | |
| GB201100455D0 (en) | Methods relating to treatment | |
| GB201121044D0 (en) | Treatment of solutions | |
| GB201109737D0 (en) | Methods of treatment | |
| GB201110602D0 (en) | Methods of treatment | |
| GB201105302D0 (en) | Treatment of acidosis | |
| IL222594A0 (en) | Combined treatment utilizing vb-201 | |
| GB201102265D0 (en) | Treatment | |
| GB201102270D0 (en) | Treatment | |
| GB201102275D0 (en) | Treatment | |
| GB201102272D0 (en) | Treatment | |
| GB201102274D0 (en) | Treatment | |
| GB201102273D0 (en) | Treatment | |
| GB201102263D0 (en) | Treatment | |
| GB201102284D0 (en) | Treatment | |
| GB201102268D0 (en) | Treatment |